Ann Arbor, MI, United States of America

William J Smith, Iii

This inventor holds 3 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1993-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William J Smith, Iii. Retrieved from https://idiyas.com/inventor/william-j-smith-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.1

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1993-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of William J. Smith, III

Introduction

William J. Smith, III is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target the central nervous system. With a total of 3 patents to his name, Smith's work has the potential to impact various medical conditions.

Latest Patents

Smith's latest patents focus on 1,3-substituted cycloalkenes and cycloalkanes. These compounds are described as useful central nervous system agents, particularly in the treatment of conditions such as hyperprolactinaemia and other central nervous system disorders. The methods for their preparation and pharmaceutical compositions are also detailed, highlighting their applications as dopaminergic, antipsychotic, and antihypertensive agents.

Career Highlights

Smith is currently associated with Warner-Lambert Company, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential therapeutic benefits, making him a key figure in his field.

Collaborations

Some of his notable coworkers include Lawrence D. Wise and David Juergen Wustrow. Their collaborative efforts contribute to the advancement of research and development in pharmaceuticals.

Conclusion

William J. Smith, III exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through his patents and collaborations are paving the way for new treatments in central nervous system disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…